Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT01196884
Other study ID # UNIT
Secondary ID
Status Unknown status
Phase
First received September 7, 2010
Last updated March 19, 2018
Start date September 2010

Study information

Verified date September 2010
Source Azienda Sanitaria-Universitaria Integrata di Udine
Contact Francesco Zaja, MD
Phone +39 0432 559604
Email zaja.francesco@aoud.sanita.fvg.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Primary ITP has wide heterogenous biology, presentation and response to therapy.

The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.


Recruitment information / eligibility

Status Unknown status
Enrollment 190
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients with primary ITP

Exclusion Criteria:

- Secondary ITP

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Italy Istituto di Ematologia L. & A. Seragnoli Bologna
Italy Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco Cagliari
Italy UF Ematologia, Policlinico di Careggi Firenze
Italy Department of Oncology/Haematology, Niguarda Ca'Granda Hospital Milano
Italy U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico Milano
Italy Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale "Amedeo Avogadro Novara
Italy Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale "Amedeo Avogadro" Novara
Italy Department of Medical and Surgical Sciences, University of Padova Padova
Italy Oncology-Hematology Department, "S. Maria delle Croci" Hospital Ravenna
Italy Institute of Hematology, Catholic University, Roma
Italy Ematologia, Ospedale Ca' Foncello Treviso
Italy Clinica Ematologica AOUD S. Maria Misericordia Udine
Italy Ematologia, San Bortolo Hospital Vicenza

Sponsors (1)

Lead Sponsor Collaborator
Azienda Sanitaria-Universitaria Integrata di Udine

Country where clinical trial is conducted

Italy, 

See also
  Status Clinical Trial Phase
Recruiting NCT04003220 - Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Recruiting NCT03633019 - High-dose Use of rhTPO in CIT Patients Phase 4
Recruiting NCT06087198 - Clinical Performance Evaluation of T-TAS®01 HD Chip
Recruiting NCT03605511 - TTP and aHUS in Complicated Pregnancies
Active, not recruiting NCT03688191 - Study of Sirolimus in CTD-TP in China Phase 4
Completed NCT02845609 - Efficacy of Sialic Acid GNE Related Thrombocytopenia Phase 2
Recruiting NCT02241031 - Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia Phase 2/Phase 3
Recruiting NCT02244658 - Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia Phase 3
Terminated NCT01368211 - Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study) Phase 2/Phase 3
Completed NCT01356576 - Effect of Hemodialysis Membranes on Platelet Count N/A
Completed NCT00039858 - Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin Phase 4
Completed NCT00787241 - Platelet Count Trends in Pre-eclamptic Parturients N/A
Completed NCT00001533 - Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine Phase 1
Not yet recruiting NCT06036966 - The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients Phase 2
Completed NCT01791101 - Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. Phase 2
Recruiting NCT06053021 - Antiplatelet Therapy for AIS Patients With Thrombocytopenia N/A
Recruiting NCT03701217 - Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML Phase 2/Phase 3
Not yet recruiting NCT05958511 - Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients
Completed NCT04917679 - Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP Phase 2